Literature DB >> 12775431

Liver ischemia: apoptosis as a central mechanism of injury.

Hannes A Rüdiger1, Rolf Graf, Pierre-Alain Clavien.   

Abstract

Injuries due to cold and warm (normothermic) ischemia remain an important source of morbidity and mortality in liver surgery and transplantation. While the mechanisms of injury are complex, involving apoptotic and necrotic types of cell death, accumulating evidence points to a central role for various apoptotic pathways in mediating cell death following ischemia. A number of antiapoptotic strategies have been shown to confer a high degree of protection, including improved animal survival following long ischemic insult. The future may lie in the identification of practical and effective antiapoptotic strategies to enhance tolerance to ischemic injury.

Entities:  

Mesh:

Year:  2003        PMID: 12775431

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  33 in total

1.  Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury.

Authors:  Sei-ichiro Tsuchihashi; Bibo Ke; Fady Kaldas; Evelyn Flynn; Ronald W Busuttil; David M Briscoe; Jerzy W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

3.  Glucagon-like peptide-2 exhibits protective effect on hepatic ischemia-reperfusion injury in rats.

Authors:  Naci Topaloğlu; Adem Küçük; Şule Yıldırım; Mustafa Tekin; Havva Erdem; Mustafa Deniz
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

4.  Ante-situm resection: a novel approach to avoid extracorporeal circulation using a transient portacaval shunt.

Authors:  Eduardo de Santibañes; Agustín Cristiano; Martin de Santibañes; Alejando Yanzon; Fanny Rodriguez Santos; Victoria Ardiles; Juan Pekolj
Journal:  HPB (Oxford)       Date:  2014-09-17       Impact factor: 3.647

5.  Establishment of a rat liver transplantation model with prolonged biliary warm ischemia time.

Authors:  Xin-Hua Zhu; Jun-Ping Pan; Ya-Fu Wu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  Prevention of trauma and hemorrhagic shock-mediated liver apoptosis by activation of stat3alpha.

Authors:  Ana Moran; Ayse Akcan Arikan; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Valeria Poli; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2008-06-15

7.  Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice.

Authors:  Lung-Yi Lee; Calvin Harberg; Kristina A Matkowskyj; Shelly Cook; Drew Roenneburg; Sabine Werner; Jeffrey Johnson; David P Foley
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

8.  PI 3-kinase pathway is responsible for antiapoptotic effects of atrial natriuretic peptide in rat liver transplantation.

Authors:  Uwe Grutzner; Melanie Keller; Michael Bach; Alexandra K Kiemer; Herbert Meissner; Manfred Bilzer; Stefan Zahler; Alexander L Gerbes; Angelika M Vollmar
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

9.  Safe time to warm ischemia and posttransplant survival of liver graft from non-heart-beating donors.

Authors:  Xiao-Shun He; Yi Ma; Lin-Wei Wu; Wei-Qiang Ju; Jin-Lang Wu; Rui-De Hu; Gui-Hua Chen; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.

Authors:  Yoichiro Uchida; Bibo Ke; Maria Cecilia S Freitas; Haofeng Ji; Danyun Zhao; Elizabeth R Benjamin; Nader Najafian; Hideo Yagita; Hisaya Akiba; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.